Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.4M
-
Number of holders
-
88
-
Total 13F shares, excl. options
-
16.5M
-
Shares change
-
-373K
-
Total reported value, excl. options
-
$187M
-
Value change
-
-$11.1M
-
Put/Call ratio
-
0.48
-
Number of buys
-
46
-
Number of sells
-
-37
-
Price
-
$11.31
Significant Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q4 2021
105 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2021.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.5M shares
of 43.4M outstanding shares and own 38.09% of the company stock.
Largest 10 shareholders include Nantahala Capital Management, LLC (2.54M shares), BlackRock Inc. (2.29M shares), STATE STREET CORP (1.66M shares), VANGUARD GROUP INC (1.55M shares), Slate Path Capital LP (1.48M shares), DIMENSIONAL FUND ADVISORS LP (849K shares), Prosight Management, LP (829K shares), GEODE CAPITAL MANAGEMENT, LLC (521K shares), Robertson Stephens Wealth Management, LLC (479K shares), and SANDERS MORRIS HARRIS LLC (359K shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.